Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | breast cancer 1, early onset | Starlite/ChEMBL | No references |
Homo sapiens | ubiquitin specific peptidase 1 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.1107 | 0.2152 | 1 |
Treponema pallidum | thymidylate kinase (tmk) | 0.0155 | 0.0204 | 0.5 |
Plasmodium vivax | thymidylate kinase, putative | 0.0155 | 0.0204 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.001 | 0.0047 |
Schistosoma mansoni | thymidylate kinase | 0.0155 | 0.0204 | 0.0204 |
Echinococcus multilocularis | transfer RNA-Ile | 0.494 | 1 | 1 |
Echinococcus granulosus | Thymidine kinase 2 mitochondrial | 0.494 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1107 | 0.2152 | 1 |
Schistosoma mansoni | thymidylate kinase | 0.0155 | 0.0204 | 0.0204 |
Brugia malayi | hypothetical protein | 0.0182 | 0.026 | 0.121 |
Echinococcus granulosus | thymidylate kinase | 0.0155 | 0.0204 | 0.0204 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.001 | 0.0047 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0306 | 0.0306 |
Echinococcus granulosus | geminin | 0.0205 | 0.0306 | 0.0306 |
Echinococcus granulosus | NADH ubiquinone oxidoreductase 42 kDa subunit | 0.1107 | 0.2152 | 0.2152 |
Entamoeba histolytica | hypothetical protein | 0.1107 | 0.2152 | 1 |
Leishmania major | thymidylate kinase-like protein | 0.0155 | 0.0204 | 1 |
Chlamydia trachomatis | thymidylate kinase | 0.0155 | 0.0204 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.1107 | 0.2152 | 1 |
Echinococcus multilocularis | thymidylate kinase | 0.0155 | 0.0204 | 0.0204 |
Plasmodium falciparum | thymidylate kinase | 0.0155 | 0.0204 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.1107 | 0.2152 | 1 |
Mycobacterium tuberculosis | Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) | 0.0155 | 0.0204 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1107 | 0.2152 | 1 |
Entamoeba histolytica | deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein | 0.1107 | 0.2152 | 1 |
Schistosoma mansoni | thymidine kinase | 0.494 | 1 | 1 |
Giardia lamblia | Deoxyguanosine kinase/deoxyadenosine kinase subunit, putative | 0.1107 | 0.2152 | 0.7231 |
Entamoeba histolytica | deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein | 0.1107 | 0.2152 | 1 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0155 | 0.0204 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.001 | 0.0047 |
Entamoeba histolytica | hypothetical protein | 0.1107 | 0.2152 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.026 | 0.121 |
Entamoeba histolytica | deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein | 0.1107 | 0.2152 | 1 |
Brugia malayi | thymidylate kinase | 0.0155 | 0.0204 | 0.0947 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1107 | 0.2152 | 1 |
Giardia lamblia | Hypothetical protein | 0.1107 | 0.2152 | 0.7231 |
Wolbachia endosymbiont of Brugia malayi | thymidylate kinase | 0.0155 | 0.0204 | 0.5 |
Schistosoma mansoni | NADH-ubiquinone oxidoreductase | 0.1107 | 0.2152 | 0.2152 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1107 | 0.2152 | 1 |
Loa Loa (eye worm) | deoxynucleoside kinase | 0.1107 | 0.2152 | 1 |
Entamoeba histolytica | hypothetical protein | 0.1107 | 0.2152 | 1 |
Toxoplasma gondii | thymidylate kinase | 0.0155 | 0.0204 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1107 | 0.2152 | 1 |
Giardia lamblia | Hypothetical protein | 0.1107 | 0.2152 | 0.7231 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.001 | 0.0047 |
Loa Loa (eye worm) | thymidylate kinase | 0.0155 | 0.0204 | 0.0947 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0155 | 0.0204 | 1 |
Entamoeba histolytica | hypothetical protein | 0.1107 | 0.2152 | 1 |
Giardia lamblia | Deoxynucleoside kinase | 0.1471 | 0.2898 | 1 |
Mycobacterium leprae | probable thymidylate kinase Tmk (dTMP KINASE) (THYMIDYLIC ACID KINASE) (TMPK) | 0.0155 | 0.0204 | 0.5 |
Echinococcus multilocularis | geminin | 0.0205 | 0.0306 | 0.0306 |
Echinococcus multilocularis | NADH ubiquinone oxidoreductase 42 kDa subunit | 0.1107 | 0.2152 | 0.2152 |
Echinococcus granulosus | thymidine kinase | 0.494 | 1 | 1 |
Entamoeba histolytica | deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein | 0.1107 | 0.2152 | 1 |
Brugia malayi | Deoxynucleoside kinase family protein | 0.1107 | 0.2152 | 1 |
Echinococcus multilocularis | thymidine kinase | 0.494 | 1 | 1 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0155 | 0.0204 | 1 |
Onchocerca volvulus | 0.0182 | 0.026 | 1 | |
Entamoeba histolytica | hypothetical protein | 0.1107 | 0.2152 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0306 | 0.0306 |
Echinococcus multilocularis | thymidine kinase | 0.494 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.1107 | 0.2152 | 1 |
Mycobacterium ulcerans | thymidylate kinase | 0.0155 | 0.0204 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0155 | 0.0204 | 0.0204 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0155 | 0.0204 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.8184 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.